Primary Health Properties Plc (JSE:PHP)
South Africa · Delayed Price · Currency is ZAR · Price in ZAc | Market Cap | 51.65B -3.2% |
| Revenue (ttm) | 7.98B +103.8% |
| Net Income | 3.46B +64.9% |
| EPS | 1.37 -9.1% |
| Shares Out | n/a |
| PE Ratio | 14.93 |
| Forward PE | 12.58 |
| Dividend | 0.40 (1.99%) |
| Ex-Dividend Date | Oct 14, 2026 |
| Volume | 1,493,453 |
| Open | 2,015.00 |
| Previous Close | 1,933.00 |
| Day's Range | 1,991.00 - 2,020.00 |
| 52-Week Range | 1,916.00 - 2,517.00 |
| Beta | 0.79 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Oct 30, 2026 |
About Primary Health Properties
Primary Health Properties Plc (PHP) is a UK Real Estate Investment Trust and leading investor in modern primary healthcare premises. We invest in flexible, modern properties for local primary healthcare. The overall objective of the group is to create progressive returns to shareholders through a combination of earnings growth and capital appreciation. To achieve this, PHP invests in healthcare real estate let on long-term leases, backed by secure underlying covenants where the majority of rental income is funded directly or indirectly by a gov... [Read more]
Financial Performance
In 2025, Primary Health Properties's revenue was 260.00 million, an increase of 42.86% compared to the previous year's 182.00 million. Earnings were 119.00 million, an increase of 190.24%.
Financial numbers in GBP Financial StatementsNews
Primary Health Properties price target raised to 115 GBp from 110 GBp at Barclays
Barclays raised the firm’s price target on Primary Health Properties (PHPRF) to 115 GBp from 110 GBp and keeps an Overweight rating on the shares.
Primary Health Properties H1 Earnings Call Highlights
Primary Health Properties LON: PHP reported a 9% increase in adjusted earnings per share for the first half of 2026, as rental growth, merger synergies and a full-period contribution from its acquisit...
Primary Health Properties Earnings Call Transcript: H1 2026
Strong H1 2026 results with 9% EPS growth, robust rental uplifts, and 30 years of dividend increases. Integration of the Assura merger is nearly complete, with substantial cost synergies realized and deleveraging on track. Portfolio fundamentals remain strong, supported by secure, government-backed income.
Primary Health Properties Quarterly report: H1 2026
Primary Health Properties has published its H1 2026 quarterly earnings report on July 30, 2026.
Primary Health Properties Slides: H1 2026
Primary Health Properties has posted slides in relation to its H1 2026 quarterly earnings report, which was published on July 30, 2026.
Primary Health Properties initiated with a Buy at Kepler Cheuvreux
Kepler Cheuvreux initiated coverage of Primary Health Properties (PHPRF) with a Buy rating and 120 GBp price target The firm sees the stock’s valuation as attractive.
Primary Health Properties Earnings release: Trading update
Primary Health Properties released its earnings on April 29, 2026, summarizing the period's financial results.
Primary Health Properties price target raised to 105 GBp at JPMorgan
JPMorgan raised the firm’s price target on Primary Health Properties (PHPRF) to 105 GBp from 100 GBp and keeps a Neutral rating on the shares.
Primary Health Properties price target raised to 115 GBp from 114 GBp at Deutsche Bank
Deutsche Bank analyst Max Nimmo raised the firm’s price target on Primary Health Properties (PHPRF) to 115 GBp from 114 GBp and keeps a Buy rating on the shares. Published…
Primary Health Properties Earnings Call Transcript: H2 2025
Delivered strong results with 4% EPS growth, 3% dividend increase, and successful Assura integration. Deleveraging on track via joint ventures, with robust rental growth and a resilient GBP 6 billion healthcare portfolio.
Primary Health Properties Annual report: H2 2025
Primary Health Properties has published its H2 2025 annual report on March 17, 2026.
Primary Health Properties Annual report: H2 2025
Primary Health Properties has published its H2 2025 annual report on March 17, 2026.
Primary Health Properties Slides: H2 2025
Primary Health Properties has posted slides in relation to its H2 2025 quarterly earnings report, which was published on March 17, 2026.
Primary Health Properties Transcript: Trading update
A transformational year marked by the Assura merger has driven rapid synergy realization, expanded development activity, and strong rental growth. Financial discipline is maintained through joint ventures, deleveraging, and a focus on refinancing, while 30 years of consecutive dividend growth continues.
Primary Health Properties Earnings release: Trading update
Primary Health Properties released its earnings on January 13, 2026, summarizing the period's financial results.
Primary Health Properties Transcript: Status Update
Strong financial results and accelerating rental growth position the business for significant expansion, supported by the NHS 10-year plan and a transformational merger with Assura. Strategic joint ventures and asset disposals will manage leverage, while a robust development pipeline and progressive dividend policy underpin future growth.
Primary Health Properties Transcript: H1 & CMD 2025
Strong H1 2025 results with rising rental income, robust portfolio metrics, and accelerating rental growth. The proposed Assura combination is set to deliver scale, synergies, and enhanced earnings, supported by the NHS 10-year plan and a focus on deleveraging and strategic JVs.
Primary Health Properties Quarterly report: H1 2025
Primary Health Properties has published its H1 2025 quarterly earnings report on July 24, 2025.
Primary Health Properties Slides: Investor presentation
Primary Health Properties has posted slides in relation to its latest quarterly earnings report, which was published on July 24, 2025.
Primary Health Properties Earnings release: Trading Update
Primary Health Properties released its earnings on July 7, 2025, summarizing the period's financial results.
UK's PHP urges Assura to back its bid over KKR-Stonepeak offer
British healthcare real estate investor Primary Health Properties (PHP) on Friday urged rival Assura to back its bid over a takeover offer from KKR and Stonepeak.